Clinical Trials Browser

Invasive Fungal Infections, Leukemia, Leukemia, Myeloid, Neutropenia, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Invasive Pulmonary Aspergillosis

NCT06245746 2025-03-21

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Phase 1 Recruiting

9 enrolled

Classical hematologyOther hematologic neoplasm

Anemia, Hemorrhage, Infections, Neutropenia, Thrombocytopenia, Leukemia, Myeloid, Acute

NCT03891576 2025-01-17

Newton

Phase 2 Terminated

83 enrolled

Classical hematologyGynecologic

Anemia, Fallopian Tube Neoplasms, Neutropenia, Ovarian Neoplasms, Recurrence, Thrombocytopenia

NCT04081753 2024-09-23

REMEDY

Phase NA Completed

12 enrolled

Other hematologic neoplasm

Fever, Leukemia, Neutropenia, Leukemia, Myeloid, Acute

NCT04187898 2024-09-19

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Phase 1 Completed

59 enrolled

Breast

Breast Neoplasms, Neutropenia

NCT06145321 2024-09-19

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

Phase 4 Active not recruiting

20 enrolled

Neoplasms, Neutropenia

NCT06075888 2024-06-24

ADNEMIA

Phase NA Recruiting

200 enrolled

Fever, Neutropenia, Viremia, Fungemia, Bacteremia

NCT06422533 2024-06-04

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

Phase NA Recruiting

226 enrolled

Other hematologic neoplasm

Neutropenia, Hematologic Neoplasms

NCT03433560 2024-05-14

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Completed

1,300 enrolled

Classical hematology

Neutropenia, Febrile Neutropenia

NCT05283616 2024-03-19

Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer

Phase 3 Completed

122 enrolled

Neutropenia

NCT05926063 2024-03-08

SAFE

Phase 4 Recruiting

410 enrolled

Classical hematologyOther hematologic neoplasm

Infections, Leukemia, Neutropenia, Febrile Neutropenia

NCT00020371 2024-03-04

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

Phase 1 Completed

Neoplasms, Neutropenia

NCT02527746 2024-02-23

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 1 Completed

18 enrolled 22 charts

Breast

Breast Neoplasms, Neutropenia

NCT00004192 2023-12-27

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

Phase 2 Completed

60 enrolled

LymphoidOther hematologic neoplasm

Burkitt Lymphoma, Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Waldenstrom Macroglobulinemia, Neutropenia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, B-Cell, Marginal Zone, Lymphoma, Mantle-Cell, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05925660 2023-12-05

MUCOPS

Phase NA Unknown

80 enrolled

Other hematologic neoplasm

Invasive Fungal Infections, Leukemia, Mucormycosis, Neutropenia

NCT01431326 2023-09-06

PTN_POPS

Completed

3,520 enrolled

CNSClassical hematology

Healthcare-Associated Pneumonia, Pulmonary Arterial Hypertension, Schizophrenia, Treatment-Resistant, Adenoviridae Infections, Anxiety Disorders, Arrhythmias, Cardiac, Autistic Disorder, Bipolar Disorder, Bradycardia, Central Nervous System Infections, Endocarditis, Epilepsy, Headache, Heart Arrest, Heart Failure, Hemophilia A, Herpes Simplex, Hyperaldosteronism, Hypertension, Hypokalemia, Infections, Inflammation, Influenza, Human, Sleep Initiation and Maintenance Disorders, Meningitis, Menorrhagia, Migraine Disorders, Neutropenia, Pain, Pneumonia, Retinitis, Schizophrenia, Seizures, Spasm, Staphylococcal Infections, Urinary Tract Infections, Meningitis, Bacterial, Cytomegalovirus Retinitis, Hemangioma, Capillary, Sepsis, Renal Insufficiency, Chronic, Intraabdominal Infections

NCT04542356 2023-09-06

Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

Phase 2 Completed

60 enrolled

Gynecologic

Uterine Cervical Neoplasms, Neutropenia

NCT05963334 2023-07-27

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Phase 1/2 Completed

49 enrolled

Classical hematology

Anemia, Neutropenia, Thrombocytopenia

NCT02536599 2023-07-24

Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia

Unknown

360 enrolled

Classical hematology

Fever, Neoplasms, Neutropenia, Febrile Neutropenia

NCT05940766 2023-07-11

Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients

Phase NA Not yet recruiting

250 enrolled

Fever, Neutropenia

NCT03252431 2023-07-03

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Phase 3 Completed

393 enrolled 20 charts

Breast

Breast Neoplasms, Neutropenia

NCT02231879 2023-04-07

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

Phase 2/3 Completed

20 enrolled 10 charts

Agammaglobulinemia, Immunologic Deficiency Syndromes, Infections, Neutropenia, Warts

NCT05793073 2023-03-31

AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients

Completed

55 enrolled

Classical hematologyOther hematologic neoplasm

Neutropenia, Hematologic Neoplasms, Febrile Neutropenia

NCT05622058 2023-02-27

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Phase 1 Terminated

6 enrolled

Breast

Alopecia, Breast Neoplasms, Neutropenia

NCT00003407 2023-02-02

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Phase 2 Withdrawn

MyeloidOther hematologic neoplasm

Blast Crisis, Leukemia, Myelodysplastic Syndromes, Neutropenia, Leukemia, Myeloid, Acute, Drug-Related Side Effects and Adverse Reactions

NCT05672420 2023-01-05

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Phase 1/2 Unknown

181 enrolled

Classical hematologyLymphoidOther hematologic neoplasmPlasma cell

Anemia, Hemorrhage, Infections, Leukemia, Lymphoma, Multiple Myeloma, Neutropenia, Thrombocytopenia, Hematologic Neoplasms

NCT05221593 2022-10-21

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients

Phase 3 Completed

50 enrolled

Neutropenia

Clinical Trials

Screening for Hematology Branch Protocols

A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

E-STOP2

the Efficacy of Leucogen in Preventing the Risk of Ribociclib-Associated Neutropenia in Early Breast Cancer

MYELO-CAN:ABX

Prospective Evaluation of Xerava Prophylaxis in Hematological Malignancy Patients With Prolonged Neutropenia

SDSR

Study of Trilaciclib and Lurbinectidin

SCREEN-IN

Real-world Study on the Prevention of Neutropenia After Tumor Treatment With Mecapegfilgrastim Injection

Comparing Diosmin-Hesperidin and Loratadine to Prevent Bone Pain From G-CSF in Patients With Blood Cancers

ANC-IIT-004

Neutropenia With TNF-α Inhibitors

PC001- A Study to Evaluate the Usability of PointCheck

Clinical Trial of a Novel Dose Adjustment Algorithm for Preventing Cytopenia-Related Delays During FOLFOX Chemotherapy

CANHPARI

LONGBOARD

BETWEEN

Revlimid® Capsules General Drug Use-results Surveillance (Relapsed or Refractory FL and MZL)

Prospective Study Evaluate the Timing of Empirical Treatment for Carbapenem-resistant Bacterials (CROEAT Study)

A Study on the Use of Sulpegfilgrastim to Prevent the Incidence of Neutropenia With Infection in Newly Diagnosed Non-transplant Multiple Myeloma Patients

Donor Stem Cell Boost in Treating Patients With Low Blood Cells After Donor Stem Cell Transplant

Study to Compare the Efficacy and Safety of F-627 and GRAN®

REDEFINE

UCMSC-Exo for Chemotherapy-induced Myelosuppression in Acute Myeloid Leukemia

Newton

REMEDY

Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer

Continuous Versus Bolus Administration of G-CSF in Children With Cancer

ADNEMIA

Ceftolozane/Tazobactam vs. Piperacillin/Tazobactam for the Treatment of Bacteremia in Hemato-oncological Patients

An Observational Study to Evaluate the Safety and Efficacy of Pegfilgrastim (Neulasta®)

Reduced Dose of Pegfilgrastim as Support for Chemotherapy for Breast Cancer

SAFE

BMS-247550 in Treating Patients With Cancers That Have Not Responded to Previous Therapy

Study of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Colony-Stimulating Factors to Relieve Neutropenia in Patients With Recurrent Non-Hodgkin's Lymphoma

MUCOPS

PTN_POPS

Study on the Efficacy and Safety of PEG-rhG-CSF in Preventing Neutropenia During Concurrent Chemoradiotherapy of Cervical Cancer

Comparison of Weekly Versus Every Three Weeks of Carboplatin Plus Paclitaxel in Patients With Advanced Epithelial Ovarian Cancer

Risk Factors & Outcomes for Clinically Documented Infections in Pediatric Cancer Patients With Fever & Neutropenia

Swiss 2024 Continous Fever Monitoring in Pediatric Oncology Patients

Neulasta-controlled Trial of F-627 in Women With Breast Cancer Receiving Myelotoxic Chemotherapy

Plerixafor Versus G-CSF in the Treatment of People With WHIM Syndrome

AMS Intervention for Early Adaptation of Empirical Antibiotic Therapy in High-risk Neutropenic Patients

A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer

Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CML

Umbilical Cord Derived Mesenchymal Stem Cells for Treatment-induced Myelosuppression in Hematologic Malignancies

Efficacy of Lithium Against Chemotherapy Induced Neutropenia in Breast Cancer Patients